Bactivax Itn

bactivax (anti-bacterial innovative vaccines) is an innovative european training network that will provide high-level training in vaccinology to 15 early stage researchers (esrs), and equip them with a wide range of transferable skills for thriving careers in vaccine research within academia and industry. bactivax will focus on developing novel vaccines to tackle the huge challenge of antimicrobial-resistant human pathogens that cause chronic, life-threatening infections. this network comprises 14 principal investigators from 8 european countries and two companies which will collectively train esrs. this project has received funding from the european union's horizon 2020 research and innovation programme under grant agreement no. 860325. this page reflects only the authors’ view and the research executive agency is not responsible for any use that may be made of the information it contains.